Medical Device Manufacturers · Texas
Vizient awarded the contract. Now their insurance schedule lands on your desk.
GPO supplier agreements (Vizient, Premier, HealthTrust) require $5M general liability, $10M products liability, additional-insured wording for the GPO and member hospitals on a primary/non-contributory basis, waiver of subrogation, and 30-day notice — every term enforced through Symplr/Reptrax credentialing.
Most mid-market device manufacturers find that a generic manufacturers package does not satisfy GPO insurance schedules. We help rebuild programs that pass vendor credentialing and respond to the long-tail products risk specific to FDA-regulated medical devices.
Problem 01 · GPO compliance
Vendor credentialing platforms are unforgiving.
Symplr/Reptrax and similar platforms enforce GPO and hospital insurance requirements by blocking purchases when COIs do not match the schedule. The product passes evaluation, the supplier passes registration — and the hospital simply cannot order from you. Most suppliers learn about the problem only when sales drop unexpectedly.
GPO floors are typically $5M general liability, $10M products liability, $25M aggregate for higher-risk implantables, with additional-insured for the GPO and member hospitals on a primary and non-contributory basis, waiver of subrogation, and 30-day notice of cancellation. The schedule is enforced precisely; near-miss wording fails.
Problem 02 · Products tower
Class II implantables push limits above $10M.
The standard $10M GPO floor is adequate for diagnostic equipment and lower-risk Class II devices. For implantables, neurostimulators, infusion pumps, and orthopedic implants, hospital procurement contracts and tort exposure both push toward $25M+ on the products tower. The ILF curve is reasonable past $10M; the structural decision is whether to layer through specialty MGAs or stay with admitted markets.
Long claim tails on implantables — sometimes 10-20 years between manufacture and claim — make occurrence-form coverage materially more valuable than claims-made. Some specialty markets only write claims-made above primary; verify each layer before binding.
Problem 03 · Connected devices
Cyber is now baseline on supplier COIs.
FDA premarket cybersecurity guidance has made cyber a baseline expectation for any device with software connectivity. Hospital procurement contracts now reference it explicitly. A standalone cyber policy with regulatory defense, notification expense, and ransomware coverage is standard for connected-device manufacturers.
The coordination question matters: a cyber event that causes a manufacturing defect (compromised firmware shipping out of spec) sits ambiguously between cyber and products liability. Programs written by carriers who play together avoid the coverage fight.
Frequently asked
Common questions from CDMO and CRO buyers
What insurance limits does a GPO supplier agreement typically require?
+
Vizient, Premier, and HealthTrust all require $5M general liability and $10M products liability minimums, with $25M aggregate common for higher-risk implantables. Plus additional-insured/primary-noncontributory wording and 30-day notice.
Do FDA Class II device makers need different coverage than Class I?
+
Yes. Class II devices typically face higher products-liability stakes (510(k) clearance implies a duty of care around substantial equivalence). Class III adds PMA-level documentation and recall response coverage.
Is cyber required for connected medical devices?
+
Increasingly yes — FDA cybersecurity guidance for premarket submissions has made cyber a baseline expectation, and hospital procurement contracts now reference it explicitly.
What does products and completed operations mean in this context?
+
Coverage for bodily injury or property damage caused by your device after it leaves your control. For medical devices, the long claim tail (decades for implantables) makes occurrence-form coverage materially more valuable than claims-made.
How do hospital vendor credentialing platforms enforce insurance?
+
Platforms like Symplr/Reptrax block purchases when COI requirements are not met. The product can be approved while the supplier is locked out due to documentation gaps. Vendors often discover this only when sales drop unexpectedly.
Do I need separate coverage for FDA recalls?
+
Standard products policies have limited recall extensions. A standalone product recall and contamination policy is recommended for finished-device manufacturers, particularly Class II implantables and Class III devices.
Free coverage review